SI – 449 is a crosslinked chondroitin sulfate developed as a medical device. It is an anti – adhesive material that spreads and swells after spraying it on surgical wound areas inside the abdominal cavity, etc., reducing postoperative adhesions. It is intended for use after laparotomy and endoscopic surgery.

Nikkei Biotech news release, November 12, 2018